Discover how O-tert-butyl-threonine modification creates potent SARS-CoV-2 main protease inhibitors with enhanced cellular potency and antiviral effectiveness.
Explore how scientists design and synthesize isatin derivatives to inhibit SARS-CoV-2 3CL protease, a key target for COVID-19 therapeutics.